Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex

References

• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science (New York) 1999; 284: 1318–1322.
   Google Scholar
• Davey ME, O'Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 2000; 64: 847–867.
   PubMed Web of Science ®Google Scholar
• O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Ann Rev Microbiol 2000; 54: 49–79.
   PubMed Web of Science ®Google Scholar
• Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001; 33: 1387–1392.
   PubMed Web of Science ®Google Scholar
• Douglas LJ. Medical importance of biofilms in Candida infections. Rev Iberoam Micol 2002; 19: 139–143.
   PubMedGoogle Scholar
• Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Inf Immun 2002; 70: 878–888.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Guimaraes T, Silva LR, . Prospective observational study of candidemia in Sao Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Cont Hosp Epidemiol 2007; 28: 570–576.
   PubMed Web of Science ®Google Scholar
• Kuhn DM, Mikherjee PK, Clark TA, . Candida parapsilosis characterization in an outbreak setting. Emerg Inf Dis 2004; 10: 1074–1081.
   PubMed Web of Science ®Google Scholar
• Kumamoto CA. Candida biofilms. Curr Opin Microbiol 2002; 5: 608–611.
   PubMed Web of Science ®Google Scholar
• Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. Candida biofilms: an update. Eukary Cell 2005; 4: 633–638.
   PubMed Web of Science ®Google Scholar
• Brito LR, Guimaraes T, Nucci M, . Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol 2006; 44: 261–266.
   PubMed Web of Science ®Google Scholar
• Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis 2001; 33: 1959–1967.
   PubMed Web of Science ®Google Scholar
• Shin JH, Kee SJ, Shin MG, . Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 2002; 40: 1244–1248.
   PubMed Web of Science ®Google Scholar
• Bizerra FC, Nakamura CV, de Poersch C, . Characteristics of biofilm formation by Candida tropicalis and antifungal resistance. FEMS Yeast Res 2008; 8: 442–450.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Nucci M, Park BJ, . Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006; 44: 2816–2823.
   PubMed Web of Science ®Google Scholar
• Krcmery V, Jr., Mrazova M, Kunova A, . Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution. Support Care Cancer 1999; 7: 428–431.
   Google Scholar
• Pfaller MA, Jones RN, Doern GV, . Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 2000; 44: 747–751.
   PubMed Web of Science ®Google Scholar
• Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 32: 452–456.
   PubMed Web of Science ®Google Scholar
• Krcmery V, Jr., Kovacicova G. Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group. Diagnos Microbiol Inf Dis 2000; 36: 7–11.
   PubMed Web of Science ®Google Scholar
• Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 2005; 43: 284–292.
   PubMed Web of Science ®Google Scholar
• Song JW, Shin JH, Shint DH, . Differences in biofilm production by three genotypes of Candida parapsilosis from clinical sources. Med Mycol 2005; 43: 657–661.
   PubMed Web of Science ®Google Scholar
• Tavanti A, Hensgens LA, Ghelardi E, Campa M, Senesi S. Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J Clin Microbiol 2007; 45: 1455–1462.
   PubMed Web of Science ®Google Scholar
• Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 2003; 41: 2961–2967.
   PubMed Web of Science ®Google Scholar
• Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001; 45: 2475–2479.
   PubMed Web of Science ®Google Scholar
• Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 1998; 36: 1450–1452.
   PubMed Web of Science ®Google Scholar
• Ramage G, Bachmann S, Patterson TF, Wickes BL, Lopez-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 2002; 49: 973–980.
   PubMed Web of Science ®Google Scholar
• Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773–1780.
   PubMed Web of Science ®Google Scholar
• Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Inf Dis 2004; 10: 14–19.
   PubMed Web of Science ®Google Scholar
• Jain N, Kohli R, Cook E, . Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol 2007; 73: 1697–1703.
   PubMed Web of Science ®Google Scholar
• Melo AS, Colombo AL, Arthington-Skaggs BA. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother 2007; 51: 3081–3088.
   PubMed Web of Science ®Google Scholar
• Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 2001; 18: 163–170.
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard. 2. Document M27-A2. Wayne, PA: NCSI.
   Google Scholar
• Colombo AL, Barchiesi F, McGough DA, Rinaldi MG. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J Clin Microbiol 1995; 33: 535–540.
   PubMed Web of Science ®Google Scholar
• Wanger A, Mills K, Nelson PW, Rex JH. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob Agents Chemother 1995; 39: 2520–2522.
   PubMed Web of Science ®Google Scholar
• Almirante B, Rodriguez D, Park BJ, . Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005; 43: 1829–1835.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, . Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309–317.
   PubMed Web of Science ®Google Scholar
• Adair CG, Gorman SP, Feron BM, . Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Int Care Med 1999; 25: 1072–1076.
   PubMed Web of Science ®Google Scholar
• Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11: 30–36.
   PubMed Web of Science ®Google Scholar
• Kuhn DM, Balkis M, Chandra J, Mukherjee PK, Ghannoum MA. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin Microbiol 2003; 41: 506–508.
   PubMed Web of Science ®Google Scholar
• Chandra J, Kuhn DM, Mukherjee PK, . Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385–5394.
   PubMed Web of Science ®Google Scholar
• Ramage G, Wickes BL, Lopez-Ribot JL. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab 2001; 20: 42–44.
   PubMedGoogle Scholar
• Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34–39.
   PubMed Web of Science ®Google Scholar
• Choi HW, Shin JH, Jung SI, . Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals. Antimicrob Agents Chemother 2007; 51: 1520–1523.
   PubMed Web of Science ®Google Scholar
• Katragkou A, Chatzimoschou A, Simitsopoulou M, . Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother 2008; 52: 357–360.
   PubMed Web of Science ®Google Scholar